Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kestra Medical TechnologiesKMTS -2.05%12 Revenue per Share is $1.75 as of Apr. 2026. GuruFocus rates KMTS with a GF Score™ of 12/100. The stock has 5 warning signs investors should review. Among 754 Medical Devices & Instruments companies, Kestra Medical Technologies ranks better than 97.08% on this metric.
Kestra Medical Technologies's revenue per share for the
three
months ended in Apr. 2026 was $0.49.
Kestra Medical Technologies's revenue per share for the trailing twelve months (TTM) ended in Apr. 2026 was $1.75.
Warning Sign:
Kestra Medical Technologies Ltd revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of Kestra Medical Technologies was -27.80% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 66.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Kestra Medical Technologies's Revenue per Share or its related term are showing as below:
KMTS'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 66 Med: 66 Max: 66
Current: 66
During the past 6 years, Kestra Medical Technologies's highest 3-Year average Revenue Per Share Growth Rate was 66.00% per year. The lowest was 66.00% per year. And the median was 66.00% per year.
KMTS's 3-Year Revenue Growth Rate is ranked better than 97.08% of 754
companies
in the Medical Devices & Instruments industry
Industry Median: 3.8
vs KMTS: 66.00
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Kestra Medical Technologies Revenue per Share Related Terms
Kestra Medical Technologies Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kestra Medical Technologies Revenue per Share Chart
KMTS vs AZTA, STAA, BLFS: Revenue per Share Comparison
For the Medical Instruments & Supplies subindustry, Kestra Medical Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kestra Medical Technologies PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kestra Medical Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where Kestra Medical Technologies's PS Ratio falls into.
Kestra Medical Technologies Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Kestra Medical Technologies's Revenue Per Share for the fiscal year that ended in Apr. 2026 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.75
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kestra Medical Technologies (KMTS) has a Revenue per Share of $1.75 as of Apr. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on Kestra Medical Technologies and its competitors. According to the industry distribution chart, Kestra Medical Technologies ranks #22 out of 754 companies in the Medical Devices & Instruments industry, placing it in the top 2.9%.
Is Kestra Medical Technologies' Revenue per Share too high?
Kestra Medical Technologies' current Revenue per Share is $1.75. The Medical Devices & Instruments industry median Revenue per Share is 3.80. Kestra Medical Technologies' value of $1.75 is 53.9% below this industry median. Based on the distribution chart, Kestra Medical Technologies ranks #22 out of 754 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Kestra Medical Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Kestra Medical Technologies' Revenue per Share compare to AZTA and STAA?
According to the Medical Devices & Instruments industry distribution chart, Kestra Medical Technologies ranks #22 out of 754 companies for Revenue per Share. This places Kestra Medical Technologies in the top 3% of its industry — outperforming the majority of peers. The industry median Revenue per Share is 3.80. Kestra Medical Technologies' value of $1.75 is 53.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Medical Devices & Instruments company?
The median Revenue per Share among Medical Devices & Instruments companies is 3.80, based on 754 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kestra Medical Technologies's current Revenue per Share of $1.75 is 53.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Kestra Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Revenue per Share is 3.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kestra Medical Technologies's current Revenue per Share is $1.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kestra Medical Technologies stock overvalued right now?
Kestra Medical Technologies (KMTS) has a current Revenue per Share of $1.75. The current Revenue per Share is $1.75 and 53.9% below the Medical Devices & Instruments industry median of 3.80. Kestra Medical Technologies' overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Kestra Medical Technologies (KMTS), the current Revenue per Share is $1.75 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
12GF Score
Get the complete analysis for KMTS
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KMTS has been successfully added to your 
